Immunovant to Present at LifeSci Partners’ Immunology and Inflammation Symposium on May 10th
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal...
Day: May 4, 2022
BrainsWay to Present Expanded Post-Marketing Clinical Research for Major Depressive Disorder at Clinical TMS Society
Additional presentations will highlight the utility of Deep TMS™ in Smoking Addiction and OCDBURLINGTON, Mass. and JERUSALEM, May 04, 2022...
Synthetic Biologics Announces Presentation on VCN-11, a Novel Oncolytic Adenovirus Designed to Evade Neutralizing Antibodies at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
- VCN-11 incorporates a proprietary albumin binding domain in the virus shell with the potential to improve systemic delivery and...
Positive 18-Month Data from Ongoing Phase 1/2 Clinical Study of AGTC-501 Presented at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting
– Data reconfirm previously highlighted safety and efficacy potential of AGTC-501 as a treatment for X-linked retinitis pigmentosa (XLRP) –...
Medolife Rx Schedules Conference Call with Investment Community to Discuss New Updates and Answer Questions
BURBANK, CA, May 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biotech company...
Aadi Bioscience Announces Unique Permanent J-code Issued for FYARRO™ from Centers for Medicare and Medicaid Services
J-Code, Effective July 1st, Will Enable a Streamlined Reimbursement Process for FYARRO™LOS ANGELES, May 04, 2022 (GLOBE NEWSWIRE) -- Aadi...
MS Society of Canada Launches MS Awareness Month Virtual Carnation Pinning, Encouraging all Elected Officials and Canadians to Participate
Campaign follows virtual Day on the Hill advocacy event asking government to #TakeActionForMSOTTAWA, May 04, 2022 (GLOBE NEWSWIRE) -- Each...
Vericel Reports First Quarter 2022 Financial Results
First Quarter Total Net Revenue of $36.1 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., May 04, 2022...
Entourage Health Partners with Pineapple Express to Provide Same-Day Medical Cannabis Delivery Service to its Starseed Medicinal Patients
Company’s upgraded medical delivery services available to its clients effective mid-May 2022TORONTO, May 04, 2022 (GLOBE NEWSWIRE) -- Entourage Health...
EyePoint Pharmaceuticals Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Developments
– Presented positive eight-month safety and efficacy data from ongoing DAVIO Phase 1 clinical trial for EYP-1901 in wet age-related...
Mindset Pharma to Participate in Upcoming Conferences in May 2022
TORONTO, May 04, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"),...
Genenta Progresses to Higher Dosing Cohort in Temferon™ Phase 1/2a Clinical Trial in Glioblastoma Multiforme
No dose limiting toxicity observed in previous three dose level cohortsRepresents a 50% higher dose than highest prior levelUpdate of...
Aptose Receives Fast Track Designation for HM43239 in Relapsed/Refractory AML Patients and FLT3 Mutation
SAN DIEGO and TORONTO, May 04, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX:...
Abeona Therapeutics Announces AAV204, a Novel AAV Capsid, Demonstrated Robust Macular Transduction Following Para-Retinal Administration in Non-Human Primates
NEW YORK and CLEVELAND, Ohio, May 04, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in...
Diffusion Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
CHARLOTTESVILLE, Va., May 04, 2022 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company...
Harvard Bioscience Announces First Quarter 2022 Financial Results
•Revenue up 7% year-over-year despite volatility in China related to COVID-19 and global supply chain headwindsHOLLISTON, Mass., May 04, 2022...
Amryt Reports Record Q1 2022 Results
Amryt Reports Record Q1 2022 Results CHMP adopts positive opinion for Filsuvez® for the treatment of Dystrophic and Junctional EB...
Akouos to Present at Bank of America 2022 Healthcare Conference
BOSTON, May 04, 2022 (GLOBE NEWSWIRE) -- Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing...
Lucira Health to Participate in Bank of America 2022 Healthcare Conference
EMERYVILLE, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused...
Oncorus Reports First Quarter 2022 Financial Results and Provides Business Updates
Additional clinical data from ONCR-177 surface lesion monotherapy expansion and combination expansion cohorts expected in second half of 2022Preclinical data...
